Correction to: Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus

被引：0
|
作者：
Neha Bhise
Megha Agarwal
Nidhi Thakur
P. S. Akshay
Sarah Cherian
Kavita Lole
机构：
[1] Indian Council of Medical Research-National Institute of Virology,Hepatitis Group
[2] Microbial Containment Complex,Bioinformatics and Data Management Group
[3] Indian Council of Medical Research-National Institute of Virology,Hepatitis Group
[4] ICMR-National Institute of Virology,Bioinformatics and Data Management Group
[5] Microbial Containment Complex,undefined
[6] ICMR-National Institute of Virology,undefined
来源：
Archives of Virology | 2023年 / 168卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
    Bhise, Neha
    Agarwal, Megha
    Thakur, Nidhi
    Akshay, P. S.
    Cherian, Sarah
    Lole, Kavita
    ARCHIVES OF VIROLOGY, 2023, 168 (05)
  • [2] Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
    Neha Bhise
    Megha Agarwal
    Nidhi Thakur
    P. S. Akshay
    Sarah Cherian
    Kavita Lole
    Archives of Virology, 2023, 168
  • [3] Correction to: Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus (vol 168, 147, 2023)
    Bhise, Neha
    Agarwal, Megha
    Thakur, Nidhi
    Akshay, P. S.
    Cherian, Sarah
    Lole, Kavita
    ARCHIVES OF VIROLOGY, 2023, 168 (07)
  • [4] In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus
    Borris Rosnay Tietcheu Galani
    Vincent Brice Ayissi Owona
    Romeo Joel Guemmogne Temdie
    Karoline Metzger
    Marie Atsama Amougou
    Pascal Dieudonné Djamen Chuisseu
    Arnaud Fondjo Kouam
    Marceline Ngounoue Djuidje
    Cécile-Marie Aliouat-Denis
    Laurence Cocquerel
    Paul Fewou Moundipa
    In Silico Pharmacology, 9 (1)
  • [5] The Antimalarial Ferroquine Is An Inhibitor of Hepatitis C Virus
    Vausselin, Thibaut
    Calland, Noemie
    Belouzard, Sandrine
    Descamps, Veronique
    Douam, Florian
    Helle, Francois
    Francois, Catherine
    Lavillette, Dimitri
    Duverlie, Gilles
    Wahid, Ahmed
    Feneant, Lucie
    Cocquerel, Laurence
    Guerardel, Yann
    Wychowski, Czeslaw
    Biot, Christophe
    Dubuisson, Jean
    HEPATOLOGY, 2013, 58 (01) : 86 - 97
  • [6] Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion
    Li, Jing
    Hu, Yangyang
    Yuan, Yifei
    Zhao, Yinan
    Han, Qiqi
    Liu, Canyu
    Hu, Xue
    Zhou, Yuan
    Wang, Yun
    Guo, Yu
    Wu, Chunchen
    Chen, Xinwen
    Pei, Rongjuan
    VIROLOGICA SINICA, 2021, 36 (03) : 501 - 509
  • [7] Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion
    Jing Li
    Yangyang Hu
    Yifei Yuan
    Yinan Zhao
    Qiqi Han
    Canyu Liu
    Xue Hu
    Yuan Zhou
    Yun Wang
    Yu Guo
    Chunchen Wu
    Xinwen Chen
    Rongjuan Pei
    Virologica Sinica, 2021, 36 (03) : 501 - 509
  • [8] Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma
    Liu, Xinyue
    Cai, Yilin
    Zhang, Yuanhao
    Zhang, Hetian
    Tian, Sisi
    Gong, Yuxia
    Song, Qinmei
    Chen, Xiaotong
    Ma, Xiao
    Wen, Yueqiang
    Chen, Yu
    Zeng, Jinhao
    PHARMACOLOGICAL RESEARCH, 2024, 210
  • [9] Hepatitis E Virus Drug Development
    Kinast, Volker
    Burkard, Thomas L.
    Todt, Daniel
    Steinmann, Eike
    VIRUSES-BASEL, 2019, 11 (06):
  • [10] Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor
    Meng, Xin
    Wang, Ye
    MOLECULES, 2021, 26 (23):
12345